Marc Y Donath
Kantonsspital Baden, Switzerland · University of Basel · Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marc Y Donath as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:29 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06047262 · Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-DiaMarc Donath · recruiting · Diabetes Mellitus, Type 2 · study chair
- Ph3NCT05401578 · Canakinumab for the Treatment of Postprandial HypoglycemiaUniversity Hospital, Basel, Switzerland · recruiting · Postprandial Hypoglycemia · principal investigator
- Ph2NCT05174507 · Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With PrediabetesUniversity Hospital, Basel, Switzerland · withdrawn · Postprandial Hypoglycemia · principal investigator
- Ph3NCT05036317 · Empagliflozin for the Treatment of Postprandial HypoglycemiaUniversity Hospital, Basel, Switzerland · terminated · Postprandial Hypoglycemia · principal investigator
- Ph2NCT04227769 · IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 DiabetesUniversity Hospital, Basel, Switzerland · terminated · Diabetes Mellitus Type 2 in Obese, Inflammation, Metabolic Disease · principal investigator
- N/ANCT03827382 · Bicycle Exercise and Lifestyle Intervention in Newly Diagnosed DiabetesUniversity Hospital, Basel, Switzerland · recruiting · Life Style · principal investigator
- Ph2NCT03174171 · Open-label Study on Treatment of Primary Aldosteronism With EverolimusUniversity Hospital, Basel, Switzerland · completed · Primary Aldosteronism · principal investigator
- N/ANCT02916355 · Role of Interleukin (IL)-1 in Postprandial Fatigue - The Chäschüechli 2 StudyUniversity Hospital, Basel, Switzerland · completed · Adiposity · principal investigator
- N/ANCT02916680 · Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot StudyUniversity Hospital, Basel, Switzerland · unknown · Type 1 Diabetes Mellitus · principal investigator
- Ph1NCT01810549 · Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake StudyUniversity of Zurich · completed · Postprandial Fatigue · principal investigator
- N/ANCT01771445 · Role of Interleukin-1 in the Regulation of Muscle Derived Interleukin-6 During ExerciseMarc Y.Donath · completed · Type 2 Diabetes · principal investigator
- Ph2NCT00303394 · Treatment of Patients With Type 2 Diabetes With an Interleukin-1 AntagonistUniversity of Zurich · completed · Type 2 Diabetes · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:29 UTC. The ranking covers the 200 most relevant of 25 PubMed records, and a shared surname and initials can bring in a namesake. All 25 on PubMed
- Interleukin-1-receptor antagonist in type 2 diabetes mellitus.N Engl J Med · 20071,448 citationsRCR 32.5
- Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.Diabetes Care · 2009314 citationsRCR 7.4
- 309 citationsRCR 8.6
- Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes.J Am Coll Cardiol · 2018279 citationsRCR 10.0
- Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.Diabetes Care · 2012231 citationsRCR 6.4
- 96 citationsRCR 5.5
- Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure.J Clin Endocrinol Metab · 199889 citationsRCR 2.3
- GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study.Diabetologia · 202078 citationsRCR 4.0
- Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans.J Clin Endocrinol Metab · 199678 citationsRCR 2.3
- Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB.J Intern Med · 200867 citationsRCR 2.7